STANFORD UNIVERSITY
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1885-11-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.stanford.edu
Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention
- First Posted Date
- 2006-02-02
- Last Posted Date
- 2017-03-09
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 30
- Registration Number
- NCT00285857
- Locations
- ๐บ๐ธ
Stanford University Cancer Center, Stanford, California, United States
Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression
- Conditions
- First Posted Date
- 2006-02-02
- Last Posted Date
- 2008-05-19
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 60
- Registration Number
- NCT00285727
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
๐บ๐ธDepression Research Clinic, Psychiatry Department, Stanford School of Medicine, Stanford, California, United States
Mild Depression 2 Week Observational Study
- Conditions
- First Posted Date
- 2006-02-02
- Last Posted Date
- 2019-09-09
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 36
- Registration Number
- NCT00285831
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
Group Cognitive Behavioral Therapy to Treat Depression in an Epilepsy Clinic Setting
- Conditions
- First Posted Date
- 2006-02-02
- Last Posted Date
- 2019-07-23
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 25
- Registration Number
- NCT00285740
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECT
- Conditions
- Interventions
- First Posted Date
- 2006-02-02
- Last Posted Date
- 2017-02-16
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 11
- Registration Number
- NCT00285818
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
L-Arginine in the Treatment of Peripheral Arterial Disease
- Conditions
- First Posted Date
- 2006-01-31
- Last Posted Date
- 2014-03-05
- Lead Sponsor
- Stanford University
- Registration Number
- NCT00284076
Molecular Genetic and Pathological Studies of Anal Tumors
- Conditions
- First Posted Date
- 2005-12-21
- Last Posted Date
- 2018-12-10
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 7
- Registration Number
- NCT00267787
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)
- Conditions
- Interventions
- First Posted Date
- 2005-12-21
- Last Posted Date
- 2017-11-13
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 1005
- Registration Number
- NCT00267774
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
๐ณ๐ฑCatharina Hospital, Eindhoven, Netherlands
Memantine Augmentation in Obsessive-Compulsive Disorder
- First Posted Date
- 2005-12-12
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 15
- Registration Number
- NCT00264238
- Locations
- ๐บ๐ธ
Stanford University School of Medicine, Stanford, California, United States
Genetics of Recurrent Early Onset Major Depression
- Conditions
- First Posted Date
- 2005-12-01
- Last Posted Date
- 2019-04-19
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 2302
- Registration Number
- NCT00260182
- Locations
- ๐บ๐ธ
Stanford University, Palo Alto, California, United States
๐บ๐ธRush University Medical Center, Chicago, Illinois, United States
๐บ๐ธJohns Hopkins University, Baltimore, Maryland, United States